PET灌注与血流评估:明日技术今日可用
定量心肌灌注PET/CT是疑似或已知冠心病患者诊断与风险分层最准确的检查之一,可综合评估区域心肌灌注、左室容积与射血分数、钙化动脉粥样硬化负荷及心肌血流量与血流储备(MFR)。负荷心肌血流量与MFR正常(>2.0)对高危阻塞性冠心病有很高阴性预测值,MFR严重降低(<1.5)提示不良事件高风险;近期证据提示血管造影阻塞性冠心病且血流储备严重降低(<1.6)者血运重建可能有预后优势,尚待随机临床试验证实。
要点
- 负荷心肌血流量与MFR>2.0对高危阻塞性冠心病有很高阴性预测值。
- 整体MFR>2.0者临床风险持续较低,MFR<1.5者不良事件风险高。
- 血管造影阻塞性冠心病且血流储备<1.6者血运重建可能有预后优势,待随机试验证实。
核心结论
- 定量心肌灌注PET/CT可综合评估区域心肌灌注、左室容积与射血分数、钙化动脉粥样硬化负荷及心肌血流量与MFR,是疑似或已知冠心病诊断与风险分层最准确的检查之一。
主要发现
- 负荷心肌血流量与MFR正常(>2.0)对高危阻塞性冠心病有很高阴性预测值,可可靠排除高危阻塞性冠心病。
- 整体MFR正常(>2.0)识别出临床风险持续较低的患者;MFR严重降低(<1.5)识别出不良事件临床高风险患者,不论其原因为阻塞性冠心病、微血管功能障碍或两者兼有。
- 用正式定量冠状动脉钙化评分或对CT透射扫描作半定量评估来刻画动脉粥样硬化负荷,对指导是否需要强化预防治疗很有帮助。
- 近期证据提示,血管造影示阻塞性冠心病且血流储备严重降低(<1.6)的患者,血运重建可能带来预后优势;该发现尚待随机临床试验证实。
关键数值与推荐
- 负荷心肌血流量与MFR>2.0对高危阻塞性冠心病有很高阴性预测值。
- 整体MFR>2.0者临床风险持续较低,MFR<1.5者不良事件临床风险高。
- 血管造影阻塞性冠心病且血流储备<1.6者血运重建可能有预后优势,尚待随机临床试验证实。
局限性
- 血管造影阻塞性冠心病且血流储备严重降低(<1.6)者血运重建可能有预后优势的发现尚待随机临床试验证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Quantitative myocardial perfusion PET/CT imaging is one of the most accurate tests for diagnosis and risk stratification of patients with suspected or known CAD. The test provides a comprehensive evaluation of patients with ischemic heart disease including quantitative assessments of regional myocardial perfusion, LV volumes and ejection fraction, calcified atherosclerotic burden, and myocardial blood flow and flow reserve (MFR). A normal stress myocardial blood flow and MFR (>2.0) has a very high negative predictive value and reliably excludes high-risk obstructive CAD. A global normal MFR (>2.0) identifies patients at consistently lower clinical risk. Conversely, a severely reduced MFR (<1.5) identifies patients at high clinical risk for adverse events regardless of whether this is due to obstructive CAD, microvascular dysfunction, or a combination of the 2. On the other hand, the delineation of atherosclerotic burden with either a formal quantitative coronary calcium score or by a semiquantitative assessment of the CT transmission scan is very helpful to guide the need for intensive preventive therapies. Recent evidence suggests that patients with angiographically obstructive CAD and a severe reduction in flow reserve (<1.6) may have a prognostic advantage from revascularization. This finding awaits confirmation by randomized clinical trials.
引用
- Di Carli MF. PET Perfusion and Flow Assessment: Tomorrows' Technology Today. Semin Nucl Med. 2020. PMID: 32284109. doi:10.1053/j.semnuclmed.2020.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。